Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "development"

3986 News Found

Vision Engineering appoints Harry Curtis as Technical Director, joins Board
People | April 20, 2026

Vision Engineering appoints Harry Curtis as Technical Director, joins Board

In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy


Health Prime appoints Nidhi Bajaj as Vice President – Human Resources
People | April 20, 2026

Health Prime appoints Nidhi Bajaj as Vice President – Human Resources

Bajaj joins Health Prime after a long and progressive tenure at Concentrix


Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study
Biotech | April 20, 2026

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols


MicrobioTx launches IBS Risk Score to enable early detection of gut disorder
Healthcare | April 20, 2026

MicrobioTx launches IBS Risk Score to enable early detection of gut disorder

The launch coincides with IBS Awareness Month in April


Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
News | April 20, 2026

Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities

PMDA is regarded among the most stringent regulatory bodies globally


Novartis CEO Vas Narasimhan joins Anthropic board
People | April 20, 2026

Novartis CEO Vas Narasimhan joins Anthropic board

Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery


C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools
Healthcare | April 20, 2026

C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools

Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits


Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
News | April 20, 2026

Eli Lilly flags counterfeit Mounjaro seizure in Gurugram

The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.


FDA pushes forward on gene-editing therapies with new safety roadmap
Biotech | April 20, 2026

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases


Precision BioSciences expands Hepatitis B gene editing trial into France and Romania
Biotech | April 20, 2026

Precision BioSciences expands Hepatitis B gene editing trial into France and Romania

The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania